Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial (Q46774434)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial |
scientific article |
Statements
1 reference
Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial (English)
1 reference
Lee M Krug
1 reference
Hedy L Kindler
1 reference
Hilary Calvert
1 reference
Christian Manegold
1 reference
Anne S Tsao
1 reference
Dean Fennell
1 reference
Ronny Öhman
1 reference
Ruth Plummer
1 reference
Wilfried E E Eberhardt
1 reference
Kazuya Fukuoka
1 reference
Rabab M Gaafar
1 reference
Jean-Jacques Lafitte
1 reference
Gunnar Hillerdal
1 reference
Quincy Chu
1 reference
Wieneke A Buikhuisen
1 reference
Gregory M Lubiniecki
1 reference
Xing Sun
1 reference
Margaret Smith
1 reference
Paul Baas
1 reference
20 March 2015
1 reference
16
1 reference
4
1 reference
447-456
1 reference